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APPENDIX 
Study Population 
    Proband dermal fibroblasts were collected under an IRB-approved protocol at the NICHD, NIH. 
These had been previously determined to synthesize type I collagen with overmodification along the 
full length of the alpha chains. The full-length cDNA for both type I collagen chains had been 
sequenced and no collagen structural mutation had been identified. 
Cell Culture 
    Human dermal fibroblasts were cultured in Dulbecco’s modified Eagle’s medium (Invitrogen, 
Carlsbad, CA) supplemented with 10% fetal bovine serum (FBS), 2 mM L-glutamine, 100 U/ml 
penicillin and 100 µg/ml streptomycin.  Conditioned media for 3-hydroxylation, differential scanning 
calorimetry and amino acid chromatography studies were prepared by incubating confluent 
fibroblasts for 24 hr in DMEM supplemented by 0.1% FBS, 50 µg/ml ascorbic acid, L-glutamine, 
penicillin and streptomycin, and collecting with protease inhibitors. 
Mutation Detection 
     Genomic DNA (gDNA) for CRTAP exons 2-7 and surrounding intronic sequences was amplified 
by standard polymerase chain reaction (Invitrogen); exon 1 was amplified with 2 primer pairs using a 
GC-rich PCR system (Roche, Basel, Switzerland).  Mutations identified by sequencing26 were 
confirmed in patient and parental fibroblast gDNA by restriction enzyme digestion. 
mRNA Levels and Alternatively Spliced Transcripts 
    Total RNA from fibroblasts was harvested using TRI Reagent (Molecular Research Center, Inc., 
Cincinnati, OH).27  For Real-Time RT-PCR (Assays-on-Demand, Applied Biosystems, Foster City, 
CA), standard curves for CRTAP and GAPDH were established using total RNA from a normal 
fibroblast control line (ATCC2127). Relative quantities of CRTAP and GAPDH were determined in 
triplicate control and patient assays using the standard curves; these values were used to calculate the 
ratio of CRTAP:GAPDH for each sample. We normalized the CRTAP:GAPDH ratio of the patients 
to that of control cells. For patients, we assayed two independent total RNA samples in triplicate.  
The cultured fibroblasts of Infant 1 were treated with with 100 µg/ml cycloheximide, prior to RT-
PCR amplification of CRTAP mRNA using Titan One Tube RT-PCR Kit (Roche) with primers 
complementary to exons 1 and 7, respectively.  
In vitro Biochemical Studies  
    For CRTAP protein analysis, fibroblasts were lysed in modified Radioimmunoprecipitation buffer 
(RIPA; 50mM Tris, pH 7.4, 1% NP-40, 150mM NaCl, 0.25% Na-deoxycholate) supplemented with a 
protease inhibitor cocktail. SDS-polyacrylamide gels of fractionated lysates were electroblotted onto 
nitrocellulose membranes (Bio-Rad, Hercules, CA) and blocked with 5% non-fat powdered milk 
prior to antibody probing. To study collagen modification, confluent fibroblasts were labeled 
overnight in serum-free media containing 260 µCi/ml [3H]-proline. Procollagen was precipitated 
from both media and cell lysates prior to pepsin digestion and electrophoresis24. Differential scanning 
calorimetry was performed from 10-50 ºC at 0.125 and 1 ºC/minute heating rates in a NanoII DSC 
instrument (Calorimetry Sciences Corporation, Lindon, UT). Amino acid chromatography was 
performed by high pressure liquid chromatography (Commonwealth Biotechnologies, Inc., 
Richmond, VA). 
    For determination of prolyl 3-hydroxylation, media from stimulated cultures were acidified and 
digested with pepsin at 4 °C for 24 hrs. Collagens were precipitated at 1.0 M NaCl and resolved by 
SDS-PAGE. The α1(I) band was excised from the gel and subjected to in-gel trypsin digestion.28 
Electrospray mass spectrometry was performed on the tryptic peptides using an LCQ Deca XP ion-
trap mass spectrometer equipped with in-line liquid chromatography (ThermoFinnigan, Waltham, 
MA), using a C8 capillary column (300 µm x 150 mm; Grace Vydac 208MS5.315) eluted at 4.5 µl 
per min. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE LEGENDS 
Supplementary Figure 1. CRTAP mutations in Recessive Lethal Osteogenesis Imperfecta  
Panel A1 shows a homozygous splice site defect in Infant 1. Restriction digestion with MwoI 
confirms that the parents (C, control; F, father; P, proband; M, mother) are heterozygous for the 
mutation, as evidenced by presence of 74 and 42 bp fragments from mutant allele as well as a 116 bp 
fragment from the normal allele. Panel A2 shows the structure of 4 alternatively spliced forms of the 
CRTAP transcript in Infant 1, determined by sequencing of subcloned RT-PCR products from total 
RNA of cycloheximide-treated cells.  The premature stop codon resulting from abnormal splicing is 
underlined.  Panel B shows a homozygous point mutation in Infant 2, and confirmation of the 
HpyCH4 III restriction site eliminated by the mutation.  Panel C displays both parental alleles in I  
nfant 3. C1 shows heterozygosity for the start codon mutation and confirms its presence in child and 
father by NlaIV digestion. C2 shows sequences of subclones separating normal exon 1 and the allele 
containing the 16 nt duplication. Digestion with HpaII confirms the maternal origin of the 
duplication. 
Supplementary Figure 2.  Biochemical Studies of Type I Collagen.  
Panel A shows a tracing of the fragmentation spectra of the peptide containing Pro986. The b and y 
ions correspond to the N-terminal (b) and C-terminal (y) daughter ions. Daughter ion y6 localizes the 
extra 16 mass units to the C-terminal 6 amino acids containing the known Pro986 site of 3-
hydroxylation. Panel B contains the thermograms of collagen melting by differential scanning 
calorimetry. The Tm of each infant’s collagen is increased about 1 °C because of overmodification, 
but there is no lower stability peak indicative of a collagen structural defect.  
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Supplementary Table 1: Modified Sillence classification of Osteogenesis Imperfecta 
 
Type Severity Clinical Features Growth 
Impairment 
Blue 
Sclera 
Dentinogenesis 
Imperfecta 
Deafness Inheritance 
I Mild Few fractures, little 
bowing of long bones 
Little to 
none 
Present A: DI absent 
 B: DI present 
Some AD 
 
II 
 
Perinatal 
Lethal 
Many perinatal 
fractures, severe 
bowing of long bones, 
undermineralization 
 
__ 
 
Present 
 
__ 
 
__ 
 
 AD, parental 
mosaicism 
III Progressive 
Deforming 
Moderate to severe 
limb bowing, many 
fractures 
Severe Variable Common Common AD 
 
IV 
 
Moderate 
Mild to moderate 
bowing of long bones, 
fractures 
  
Moderate 
Present 
or absent 
A: DI absent 
 B: DI present 
 
Some 
 
AD 
 
Modified from the original Sillence classification2 
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